icatibant [4034]
icatibant
| SMILES | NC(N)=NCCCC(NC(=O)[C@H](N)CCCN=C(N)N)C(=O)N1CCCC1C(=O)N1C[C@H](O)CC1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2CC1C(=O)N1C(C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C[C@@H]2CCCC[C@@H]21 |
| InChIKey | QURWXBZNHXJZBE-MCDGZUPGSA-N |
| Sequence | RRPXGXSXXR |
| HELM | PEPTIDE1{[dR].R.P.[Hyp].G.[Thi].S.[dTic].[Phi].R}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 17 |
| Hydrogen bond donors | 15 |
| Rotatable bonds | 30 |
| Log P | -5.023 |
| Molecular weight (Da) | 1303.7 |
| Stereochemistry info | partial |
Database connections
| Model (Boltz2) | B2 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
icatibant
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
2
Phase III
0
Phase IV
1
Database connections
| Model (Boltz2) | B2 |
Sankey plot
Drug Information
| Target | Disease | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gene | Protein | Receptor family | Ligand type | Class | Name | Phase | ICD11 | ATC | Association score |